BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9516831)

  • 1. Loss of heterozygosity for chromosome 1p in familial neuroblastoma.
    Tonini GP; Lo Cunsolo C; Cusano R; Iolascon A; Dagnino M; Conte M; Milanaccio C; De Bernardi B; Mazzocco K; Scaruffi P
    Eur J Cancer; 1997 Oct; 33(12):1953-6. PubMed ID: 9516831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome.
    Iolascon A; Lo Cunsolo C; Giordani L; Cusano R; Mazzocco K; Boumgartner M; Ghisellini P; Faienza MF; Boni L; De Bernardi B; Conte M; Romeo G; Tonini GP
    Cancer Lett; 1998 Aug; 130(1-2):83-92. PubMed ID: 9751260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
    Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
    Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted.
    Caron H; Spieker N; Godfried M; Veenstra M; van Sluis P; de Kraker J; Voûte P; Versteeg R
    Genes Chromosomes Cancer; 2001 Feb; 30(2):168-74. PubMed ID: 11135433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
    Hogarty MD; Winter CL; Liu X; Guo C; White PS; Look AT; Brodeur GM; Maris JM
    Cancer Res; 2002 Nov; 62(22):6481-4. PubMed ID: 12438240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma.
    Godfried MB; Veenstra M; Valent A; Sluis Pv; Voûte PA; Versteeg R; Caron HN
    Eur J Cancer; 2002 Jul; 38(11):1513-9. PubMed ID: 12110498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development.
    Lo Cunsolo C; Iolascon A; Cavazzana A; Cusano R; Strigini P; Mazzocco K; Giordani L; Massimo L; De Bernardi B; Conte M; Tonini GP
    Cancer Genet Cytogenet; 1999 Mar; 109(2):126-30. PubMed ID: 10087945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.
    White PS; Maris JM; Sulman EP; Jensen SJ; Kyemba SM; Beltinger CP; Allen C; Kramer DL; Biegel JA; Brodeur GM
    Eur J Cancer; 1997 Oct; 33(12):1957-61. PubMed ID: 9516832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
    Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM
    Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.
    Martinsson T; Sjöberg RM; Hallstensson K; Nordling M; Hedborg F; Kogner P
    Eur J Cancer; 1997 Oct; 33(12):1997-2001. PubMed ID: 9516841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma.
    Komuro H; Valentine MB; Rowe ST; Kidd VJ; Makino S; Brodeur GM; Cohn SL; Look AT
    J Pediatr Surg; 1998 Nov; 33(11):1695-8. PubMed ID: 9856898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
    Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients.
    Perri P; Pession A; Mazzocco K; Scaruffi P; Strigini P; Iolascon A; Albergoni MP; Basso G; Tonini GP
    Eur J Cancer; 1997 Oct; 33(12):1949-52. PubMed ID: 9516830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T
    Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.
    Ambros PF; Ambros IM; Kerbl R; Luegmayr A; Rumpler S; Ladenstein R; Amann G; Kovar H; Horcher E; De Bernardi B; Michon J; Gadner H
    Med Pediatr Oncol; 2001 Jan; 36(1):1-4. PubMed ID: 11464855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas.
    Tong CY; Ng HK; Pang JC; Hu J; Hui AB; Poon WS
    Histopathology; 2000 Aug; 37(2):160-5. PubMed ID: 10931240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
    Rubie H; Delattre O; Hartmann O; Combaret V; Michon J; Bénard J; Peyroulet MC; Plantaz D; Coze C; Chastagner P; Baranzelli MC; Frappaz D; Lemerle J; Sommelet D
    Eur J Cancer; 1997 Oct; 33(12):1917-22. PubMed ID: 9516824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.